E-LIB Suche - Ergebnisse für: Paik, Paul K

1

PP01.83 Treatment Sequencing in the VISION Study of Tepotin..:

Griesinger, Frank ; Garassino, Marina ; Felip, Enriqueta...
Journal of Thoracic Oncology. 19 (2024) 7 - p. e37-e38 , 2024

Link: https://doi.org/10.1016/..

2

PPD01.01 ctDNA Dynamics, Prognostic Markers and Resistance ..:

Le, Xiuning ; Garassino, Marina Chiara ; Ahn, Myung-Ju...
Journal of Thoracic Oncology. 19 (2024) 7 - p. e4 , 2024

Link: https://doi.org/10.1016/..

3

Initial Chemotherapy for Locally Advanced and Metastatic NU..:

Luo, Jia ; Sanchez, Michelle ; Lee, Elinton...
Journal of Thoracic Oncology. 19 (2024) 5 - p. 829-838 , 2024

Link: https://doi.org/10.1016/..

4

Modelling the Effectiveness of Tepotinib in Comparison to S..:

Batteson, Rachael ; Hook, Emma ; Wheat, Hollie...
Targeted Oncology. 19 (2024) 2 - p. 191-201 , 2024

Link: https://doi.org/10.1007/..

5

Microsatellite Instability and Mismatch Repair Deficiency D..:

Yang, Soo-Ryum ; Gedvilaite, Erika ; Ptashkin, Ryan...
Journal of Thoracic Oncology. 19 (2024) 3 - p. 409-424 , 2024

Link: https://doi.org/10.1016/..

6

Efficacy and safety of tepotinib in Asian patients with adv..:

Kato, Terufumi ; Yang, James Chih-Hsin ; Ahn, Myung-Ju...
British Journal of Cancer. 130 (2024) 10 - p. 1679-1686 , 2024

Link: https://doi.org/10.1038/..

7

Biomarkers associated with pulmonary exacerbations in a ran..:

Moore, Zachary R. ; Huang, Xiaojing ; Lobaugh, Stephanie...
Radiotherapy and Oncology. 196 (2024) - p. 110320 , 2024

Link: https://doi.org/10.1016/..

8

Long‐term experience with tepotinib in Japanese patients wi..:

Morise, Masahiro ; Kato, Terufumi ; Matsumoto, Shingo...
Cancer Science. 115 (2024) 4 - p. 1296-1305 , 2024

Link: https://doi.org/10.1111/..

9

Randomized Phase 2 Placebo-Controlled Trial of Nintedanib f..:

Rimner, Andreas ; Moore, Zachary R. ; Lobaugh, Stephanie...
International Journal of Radiation Oncology*Biology*Physics. 116 (2023) 5 - p. 1091-1099 , 2023

Link: https://doi.org/10.1016/..

10

Tepotinib in patients with non-small cell lung cancer with ..:

Le, Xiuning ; Paz-Ares, Luis G. ; Van Meerbeeck, Jan...
Cell Reports Medicine. 4 (2023) 11 - p. 101280 , 2023

Link: https://doi.org/10.1016/..

11

Health Utility Analysis of Tepotinib in Patients With Non-S..:

Yang, Mo ; Vioix, Helene ; Hook, Emma S....
Value in Health. 26 (2023) 8 - p. 1155-1163 , 2023

Link: https://doi.org/10.1016/..

12

Plain language summary of the development of tepotinib: a t..:

Hallick, John ; Baird, Anne-Marie ; Falchook, Gerald...
Future Oncology. 19 (2023) 10 - p. 683-696 , 2023

Link: https://doi.org/10.2217/..

13

Targeting NFE2L2/KEAP1 Mutations in Advanced NSCLC With the..:

Paik, Paul K. ; Fan, Pang-Dian ; Qeriqi, Besnik...
Journal of Thoracic Oncology. 18 (2023) 4 - p. 516-526 , 2023

Link: https://doi.org/10.1016/..

14

Cost-Effectiveness of Tepotinib Versus Capmatinib for the T..:

Yang, Mo ; Vioix, Helene ; Sachdev, Rameet...
Value in Health. 26 (2023) 4 - p. 487-497 , 2023

Link: https://doi.org/10.1016/..

15

Real-world outcomes in non-small-cell lung cancer patients ..:

Paik, Paul K ; Goyal, Ravi K ; Cai, Beilei...
Future Oncology. 19 (2023) 3 - p. 217-228 , 2023

Link: https://doi.org/10.2217/..